Butirosin is an aminoglycoside antibiotic that is primarily derived from the bacterium Micromonospora purpurea. It is characterized by its ability to inhibit bacterial protein synthesis, making it effective against a range of Gram-positive and some Gram-negative bacteria. The structure of butirosin includes a unique sugar moiety, which contributes to its antimicrobial activity. It is known for its relatively low toxicity compared to other aminoglycosides, which makes it a candidate for therapeutic applications. Butirosin has been studied for its potential use in treating infections, particularly those caused by resistant strains of bacteria. Its mechanism of action involves binding to the bacterial ribosome, disrupting the translation process, and ultimately leading to cell death. Additionally, butirosin's stability and solubility in various solvents are important characteristics that influence its formulation and delivery in clinical settings. Overall, butirosin represents a significant compound in the field of antibiotic research, particularly in the context of combating antibiotic resistance.

Butirosin

12772-35-9: Butirosin is an aminoglycoside antibiotic that is primarily derived from the bacterium Micromonospora purpurea. It is characterized by its ability to inhibit bacterial protein synthesis, making it effective against a range of Gram-positive and some Gram-negative bacteria. The structure of butirosin includes a unique sugar moiety, which contributes to its antimicrobial activity. It is known for its relatively low toxicity compared to other aminoglycosides, which makes it a candidate for therapeutic applications. Butirosin has been studied for its potential use in treating infections, particularly those caused by resistant strains of bacteria. Its mechanism of action involves binding to the bacterial ribosome, disrupting the translation process, and ultimately leading to cell death. Additionally, butirosin's stability and solubility in various solvents are important characteristics that influence its formulation and delivery in clinical settings. Overall, butirosin represents a significant compound in the field of antibiotic research, particularly in the context of combating antibiotic resistance.

CAS 12772-35-9

Butirosin